CIC Mauricie Inc.

Trois-Rivières, Quebec G8T 7A1

1 studies enrolling now · 9 studies all time

What they study most

Asthma, Cardiovascular Disease, Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease, Hyperlipidemia, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial, Moderate to Severe Chronic Obstructive Pulmonary Disease, Obesity, Obstructive Sleep Apnea, Osteoarthritis, Knee, Overweight

Studies at this site

• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease — Recruiting now
• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight — Completed
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) — Completed
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma — Completed